377 related articles for article (PubMed ID: 17944761)
1. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
[TBL] [Abstract][Full Text] [Related]
2. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
[TBL] [Abstract][Full Text] [Related]
3. Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia.
Ahn S; Lee YS; Lim KS; Lee JL
Support Care Cancer; 2013 Aug; 21(8):2303-8. PubMed ID: 23519568
[TBL] [Abstract][Full Text] [Related]
4. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
[TBL] [Abstract][Full Text] [Related]
5. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
6. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.
Miedema KG; de Bont ES; Elferink RF; van Vliet MJ; Nijhuis CS; Kamps WA; Tissing WJ
Support Care Cancer; 2011 Oct; 19(10):1593-600. PubMed ID: 20803037
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients.
Qu J; L X; Liu Y; Wang X
Indian J Med Res; 2015 Mar; 141(3):315-21. PubMed ID: 25963492
[TBL] [Abstract][Full Text] [Related]
10. [Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia].
Fu Y; Jiang H; Li LX; Chen J; Zhang JL; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1296-300. PubMed ID: 24156453
[TBL] [Abstract][Full Text] [Related]
11. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
[TBL] [Abstract][Full Text] [Related]
13. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of bacteraemia in low-risk patients with febrile neutropenia.
Ahn S; Lee YS; Chun YH; Lim KS; Kim W; Lee JL
Emerg Med J; 2012 Sep; 29(9):715-9. PubMed ID: 22011971
[TBL] [Abstract][Full Text] [Related]
16. Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever.
Bilgir O; Bilgir F; Kebapcilar L; Bozkaya G; Çalan M; Kırbıyık H; Avci M; Sari İ; Yuksel A; Isikyakar T
Transfus Apher Sci; 2012 Feb; 46(1):19-24. PubMed ID: 22079264
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a pilot study.
Kwofie L; Rapoport BL; Fickl H; Meyer PW; Rheeder P; Hlope H; Anderson R; Tintinger GR
Ann Hematol; 2012 Apr; 91(4):605-11. PubMed ID: 21976106
[TBL] [Abstract][Full Text] [Related]
18. Alterations of serum cytokine levels and their relation with inflammatory markers in candidemia.
Akin H; Akalin H; Budak F; Ener B; Ocakoğlu G; Gürcüoğlu E; Göral G; Oral HB
Med Mycol; 2015 Apr; 53(3):258-68. PubMed ID: 25627661
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever.
Fraunberger P; Wang Y; Holler E; Parhofer KG; Nagel D; Walli AK; Seidel D
Shock; 2006 Jul; 26(1):10-2. PubMed ID: 16783191
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia.
Hatzistilianou M; Rekliti A; Athanassiadou F; Catriu D
Inflamm Res; 2010 May; 59(5):339-47. PubMed ID: 19806318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
